Nov 2, 2022 by James HalleyWhy Horizon Therapeutics' Shares Rose 11.32% on WednesdayThe company released encouraging year-end guidance.
Nov 2, 2022 by James HalleyWhy Denali Therapeutics' Stock Rose 6.6% on WednesdayThe biopharmaceutical stock was actually up as much as 12.4% before falling a bit at the close.
Nov 1, 2022 by James HalleyWhy Shares of atai Life Sciences Climbed 14.58% on TuesdayThe company specializes in developing psychedelics as therapies.
Nov 1, 2022 by James HalleyWhy Shares of Compugen Jumped 9.27% on TuesdayThe stock's rise came after the company announced when third-quarter earnings will be presented.
Nov 1, 2022 by James Halley2 High-Performing, High-Yield Medical Dividend Stocks to Buy NowBoth REITS have come through the pandemic relatively healthy and are poised to grow.
Oct 31, 2022 by James HalleyWhy Shares of Zymeworks Rose 12.18% on MondayThe biotech stock's shares may have been pushed by a short squeeze.
Oct 31, 2022 by James Halley2 On-Fire Biotech Stocks That Are Crushing the Bear MarketThe biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.
Oct 31, 2022 by James HalleyAre Any of These 3 Robinhood Cannabis Favorites a Buy?These Canadian cannabis companies have seen their shares plummet this year.
Oct 29, 2022 by James HalleyWhy Shares of Vaxcyte Rose 110.7% This WeekThe company released early data for a promising pneumonia vaccine.
Oct 28, 2022 by James HalleyWhy Shares of Universal Health Services Spiked 30% This WeekThe hospital and behavioral health company grew revenue but saw earnings per share drop.
Oct 28, 2022 by James HalleyWhy Shares of Vertex Pharmaceuticals Jumped 9.03% on FridayA strong earnings report after the close on Thursday pushed the stock higher all day Friday.
Oct 28, 2022 by James HalleyWhy Medpace Holdings Jumped 41.5% This WeekThe clinical contract research organization is seeing an increase in new business.
Oct 28, 2022 by James Halley3 Under-the-Radar Cannabis Stocks to Buy Right NowThree cannabis stocks are getting overlooked despite strong performances.
Oct 27, 2022 by James HalleyWhy BioMarin Pharmaceuticals Fell 6.9% on ThursdayInvestors were expecting better top-line numbers from the company's earnings report.
Oct 27, 2022 by James HalleyIs BioNTech a Good Long-Term Buy?BioNTech has a burgeoning oncology portfolio up its sleeve.
Oct 26, 2022 by James Halley3 Medical Stocks On the ReboundAs surgeries bounce back toward pre-pandemic levels, these three companies should benefit.
Oct 26, 2022 by James Halley2 High-Yielding Dividend Stocks Worth the Risk and 1 That Isn'tNot all medical REITs are created equal.
Oct 25, 2022 by James HalleyWhy Bionano Genomics' Shares Spiked 16.42% on TuesdayOn an up day for Wall Street, the genome-mapping company may have benefited from a short squeeze.
Oct 25, 2022 by James HalleyWhy Rite Aid's Shares Jumped 15.3% on TuesdayThe beleaguered drugstore company's shares got a shot in the arm from President Joe Biden.
Oct 25, 2022 by James Halley2 Pharma Stocks With Blockbuster Drugs on the HorizonEli Lilly and Bristol Myers Squibb should benefit from two unique therapies.
